EUCTR2012-004313-13-SE进行中（未招募）不适用
A prospective study of the use of 68Ga-DOTA-TATE PET/CT in patients with neuroendocrine tumors.
Skåne University Hospital, Dept of Oncology0 个研究点目标入组 450 人开始时间: 2012年10月24日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 450
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Age 18 years or more
- •Signed written informed concent
- •Follow up of previous diagnosed neuroendocrine tumor or is under investigation for suspect neuroendocrine tumor
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 135
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 315
排除标准
- •Pregnancy or breastfeeding
- •Age less than 18 years
研究者
相似试验
已完成
不适用
Study to Measure the Safety of 68Ga-DOTA-TATE PET/CT in the Diagnosis of Tumors Expressing Somatostatin ReceptorsNeuroendocrine TumorsNCT02810600Centre de recherche du Centre hospitalier universitaire de Sherbrooke2,120
进行中（未招募）
不适用
se of 68Ga-DOTA-NOC for the evaluation of patients with Idiopathic pulmonary fibrosisSTUDY CODE: 68Ga-DOTA-NOC/ILD 01/2008 - 68Ga-DOTA-NOC/ILD01/2008EUCTR2008-007168-40-ITAZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
已完成
3 期
A Prospective, Open-label Study of [68Ga]Ga-DOTA-TATE in Patients With Neuroendocrine Neoplasms (NENs) and Healthy Volunteers in JapanNeuroendocrine NeoplasmsNCT06240741Novartis Pharmaceuticals71
终止
1 期
68Ga-Dotatoc Positron Emission Tomography (PET) for Somatostatin Receptor-Positive Neuroendocrine Tumors (NETs)Neuroendocrine TumorsCarcinoid TumorsNCT02359500Lale Kostakoglu71
招募中
3 期
68Ga-DOTA-TATE PET/CT Imaging in NETsNeuroendocrine TumorsNCT04847505Centre de recherche du Centre hospitalier universitaire de Sherbrooke5,000